Los Angeles Capital Management LLC Makes New Investment in Align Technology, Inc. $ALGN

Los Angeles Capital Management LLC acquired a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) during the second quarter, HoldingsChannel.com reports. The firm acquired 1,489 shares of the medical equipment provider’s stock, valued at approximately $282,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Redmond Asset Management LLC raised its holdings in Align Technology by 2.0% during the 1st quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock valued at $440,000 after buying an additional 54 shares during the period. Horizon Investments LLC raised its stake in shares of Align Technology by 6.2% in the first quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock valued at $162,000 after acquiring an additional 59 shares during the period. Atria Investments Inc raised its stake in shares of Align Technology by 4.9% in the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock valued at $298,000 after acquiring an additional 74 shares during the period. IFP Advisors Inc lifted its holdings in shares of Align Technology by 5.7% in the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 77 shares during the last quarter. Finally, Covestor Ltd boosted its stake in shares of Align Technology by 18.8% during the 1st quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after purchasing an additional 78 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Analysts Set New Price Targets

ALGN has been the subject of several analyst reports. Jefferies Financial Group raised their price objective on shares of Align Technology from $140.00 to $155.00 in a research note on Thursday, October 30th. Piper Sandler reissued an “overweight” rating and set a $200.00 price target (up from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. Weiss Ratings downgraded Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Morgan Stanley lifted their target price on Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. Finally, Wall Street Zen raised shares of Align Technology from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Align Technology currently has an average rating of “Hold” and an average target price of $175.45.

Align Technology Stock Down 1.6%

Shares of NASDAQ ALGN opened at $137.13 on Monday. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $246.19. The firm has a market cap of $9.84 billion, a PE ratio of 26.58, a price-to-earnings-growth ratio of 1.49 and a beta of 1.84. The business has a fifty day simple moving average of $132.91 and a two-hundred day simple moving average of $159.04.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, beating the consensus estimate of $2.38 by $0.23. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The firm had revenue of $995.69 million for the quarter, compared to analyst estimates of $980.75 million. During the same quarter last year, the firm posted $2.35 earnings per share. The business’s revenue for the quarter was up 1.8% on a year-over-year basis. Align Technology has set its Q4 2025 guidance at EPS. On average, research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its board has approved a share buyback plan on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.